Fall 2022/Winter 2023

Research highlights from the BC Renal network

Low dose steroids limit kidney damage in patients with IgA nephropathy

It has long been uncertain whether the benefits of treating IgA nephropathy, an immune-related form of kidney disease, with steroids outweigh the risks. However, a recent, large-scale study published last May with JAMA finally offers more definitive evidence. The results suggest that treating IgA nephropathy with a six-month course of low- to moderate-dose steroids can safely reduce the amounts of permanent kidney damage patients will experience.

Read More

Non-dialysis kidney patients benefit greatly from COVID-19 vaccination

A new study shows that non-dialysis kidney patients who are vaccinated have a significantly reduced risk of COVID-19 infection – up to 78% with three vaccine doses – compared to their non-vaccinated time period. The results, which also show that vaccines significantly reduce risk of hospitalization and death from the virus in this population, were published this September in Kidney International.

Read More

Updated clinical tool assesses risk of IgA nephropathy progression over time

In an important advance for precision medicine, researchers have refined a tool used to predict which people living with IgA nephropathy are likely to experience disease progression. The original prediction tool is used at the time when patients first receive their diagnosis, but this second version can be used at the one- or two-year mark after diagnosis to better inform ongoing treatment decisions.

Read More

Pediatric transplant patients benefit from texting with their care teams

In the search for alternative ways to connect with their pediatric transplant patients, clinicians at BC Children’s Hospital piloted a novel project whereby they completed weekly check-ins with their patients via text. The results, published in Pediatric Transplant earlier this year, show how the approach can enhance the health care experience for this population.

Read More

Researcher profile: Dr. Mike Bevilacqua

Dr. Mike Bevilacqua is a Fraser Health nephrologist based in Surrey, British Columbia, who has dedicated the past seven years of his work life as a health care provider for people living with kidney disease. But his interests also extend to driving systems-level changes in the delivery of kidney care, and he has taken on numerous quality improvement and research initiatives to reach these goals.

Read More

Staff profile: Catherine Turner, Indigenous Liaison Manager, Can-SOLVE CKD Network

Historically, research has been done unilaterally on, rather than with, Indigenous people in Canada, which has exacerbated health inequities. But some people are working hard to change this status quo, including Catherine Turner.

Read More


PHSA Updates:

Introducing PHSA’s New Research Roadmap: PHSA has unveiled its research roadmap, a three-year strategic initiative to strengthen the PHSA’s research enterprise. Learn more here: Research Roadmap (phsa.ca)

Conflict of Interest (COI) Reminder: Researchers affiliated with PHSA, its research institutes and its programs, must fill out an online conflict of interest form, even to declare no conflicts. COIs must be updated annually. Forms can be filled out here: Conflict of Interest (phsa.ca)


Who We Are:
Kidney care professionals and patient partners across BC are engaged in a broad range of local, provincial and international research projects, many in collaboration with BC's educational and research institutions. Their work is frequently published in peer-reviewed journals.

Why We Do It:
● To facilitate/conduct quality research studies
● To support knowledge translation
● To foster local, national and international research collaborations
● To facilitate training and mentoring of young physicians and scientists

Subscribe to this newsletter

You may unsubscribe at any time by clicking on the unsubscribe button below or emailing Research Communications at bcrenal@bcrenal.ca